Abstract:Importance: There is some support for the existence of genetic associations between adiposity and certain hepatobiliary diseases in Western populations. However, there is little evidence of such genetic associations in China, where the causes of these diseases may differ from those in Western populations and the mean body mass index (BMI) is much lower.Objectives: To compare the observational associations of BMI with hepatobiliary diseases and liver biomarkers with the genetic associations between BMI and these factors and to assess whether the genetic associations of BMI with liver diseases differed by hepatitis B virus infection status.Design, Setting, and Participants: This cohort study used data from the prospective China Kadoorie Biobank, including 473 938 adults aged 30 to 79 years without hepatobiliary diseases at baseline from 10 diverse areas in China from June 25, 2004, to July 15, 2008. A random sample of 75 736 participants with genotyping data was included in the Mendelian randomization analysis. Follow-up was completed January 1, 2017 (median [interquartile range] length of follow-up, 10.2 [9.2-11.1] years). Data were analyzed from January to October 2019.Exposures: Measured BMI obtained during the baseline survey and genetically instrumented BMI derived using 92 single-nucleotide variations.Main Outcomes and Measures: Incident cases of hepatobiliary diseases, liver enzymes, fatty liver index, and fibrosis score.Results: Among 473 938 individuals (276 041 [58.2%] women), the mean (SD) age was 52 (10.9) years and mean (SD) BMI was 23.8 (3.4). Baseline BMI was associated with higher risks of chronic liver disease (adjusted risk ratio per 1-SD increase, 1.14; 95% CI, 1.11 to 1.17) and gallbladder disease (adjusted risk ratio per 1-SD increase, 1.29; 95% CI, 1.27 to 1.31), with heterogeneity by disease subtype (P < .001). Genetically instrumented BMI was associated with higher risks of chronic liver disease (risk ratio per 1-SD increase, 1.55; 95% CI, 1.08 to 2.24) and gallbladder disease (risk ratio per 1-SD increase, 1.40; 95% CI, 1.11 to 1.76), with no heterogeneity between subtypes. A meta-analysis of the genetic associations in China Kadoorie Biobank and those calculated in UK Biobank gave a risk ratio of 1.55 (95% CI, 1.30 to 1.84) for chronic liver disease and 1.42 (95% CI, 1.22 to 1.64) for gallbladder disease. In the China Kadoorie Biobank study, there were positive genetic associations of BMI with liver enzymes, steatosis, and fibrosis scores, consistent with observational associations. The genetic associations of BMI with liver diseases and biomarkers did not differ by hepatitis B virus infection status.Conclusions and Relevance: In this cohort study of a relatively lean Chinese population, there were positive genetic associations of BMI with hepatobiliary diseases. These results suggest that maintaining a healthy weight through diet and physical activity may help prevent hepatobiliary diseases.

Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies.

Body Mass Index and Risk of Primary Liver Cancer: A Meta-Analysis of Prospective Studies

Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study

Regional and sex differences in the mortality risk of primary liver cancer in obesity: a systematic review and meta-analysis

Waist Circumference Might Be a Predictor of Primary Liver Cancer: A Population-Based Cohort Study

The association between BMI and gallbladder cancer risk: a meta-analysis.

Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies

Body mass index and risk of BPH: a meta-analysis

Excess Body Weight and Gastrointestinal Cancer Risk

Body Size and the Risk of Biliary Tract Cancer: a Population-Based Study in China

Body mass index trajectories, weight gain and risks of liver and biliary tract cancers.

Central Adiposity in Relation to Risk of Liver Cancer in Chinese Adults: A Prospective Study of 0.5 Million People

Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis.

The association between fasting blood glucose and the risk of primary liver cancer in Chinese males: a population-based prospective study

Cumulative Evidence for Relationship Between Body Mass Index and Risk of Esophageal Cancer: An Updated Meta-Analysis with Evidence from 25 Observational Studies.

Body Size Indicators And Risk Of Gallbladder Cancer: Pooled Analysis Of Individual-Level Data From 19 Prospective Cohort Studies

Unveiling the Protective Role of Metabolic and Bariatric Surgery Against Primary Liver Cancer in Obesity - A Nationwide French Administrative Data Study.

Incidence of liver complications with hemochromatosis associated HFE p.C282Y homozygosity: The role of central adiposity

Investigating the causal association between obesity and risk of hepatocellular carcinoma and underlying mechanisms

Observational and Genetic Associations of Body Mass Index and Hepatobiliary Diseases in a Relatively Lean Chinese Population